What is the long-term trend for Bio-Rad Laboratories's life science — goodwill, period increase (decrease)?

Over 3 years (2021 to 2025), Bio-Rad Laboratories's life science — goodwill, period increase (decrease) has grown at a 43.0% compound annual growth rate (CAGR), from $55.4M to $162.1M.

What does life science — goodwill, period increase (decrease) mean?

The net change in the goodwill balance for the Life Science segment during the reporting period. This includes new acquisitions, divestitures, and adjustments for impairment or currency translation.

Bio-Rad Laboratories BIO Life Science — Goodwill, Period Increase (Decrease)

Other segment segments

Clinical Diagnostics

$0-100%

Similar metrics at other companies

RVTYLife Sciences — Goodwill

$4.75B+3.9%

DCILife Sciences Segment — Goodwill

$172.8M+2.2%

RVTYLife Sciences — Goodwill, Acquisition

$32.04M—

DCILife Sciences Segment — Goodwill, Foreign Currency Translation, Gain (Loss)

$3.9M+172%

DHRLife Sciences — Goodwill, Foreign Currency Translation, Gain (Loss)

$135.5M+374%

TMOLife Sciences Solutions — Goodwill

$14.91B+20.9%

Other financials

Income statement

See full

Revenue$592.1M+1.1%

Gross profit$309.4M+1.1%

Operating income$34.1M+43.9%

Net income-$527.1M-924%

EPS (diluted)-$19.55-954%

Balance sheet

See full

Cash & equivalents$509.0M-2.7%

Total debt$987.3M-28.4%

Total equity$6.9B+2.6%

Total assets$9.8B+2.8%

Cash flow

See full

Operating cash flow$108.1M-16.8%

CapEx$30.0M-12.8%

Free cash flow$78.1M-18.2%

Valuation

See full

Market cap$7.56B+10.3%

Enterprise value$8.04B+4.2%

P/E44.8×—

P/S2.9×+0.2×

Profitability

See full

Gross margin51.9%-1.6pp

Operating margin8.8%-3.1pp

Net margin6.5%+3.4pp

FCF margin13.8%-0.2pp

Returns & leverage

See full

Return on equity2.5%+1.3pp

Debt / equity0.1×-0.1×

Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:GoodwillPeriodIncreaseDecrease.

The official record: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bio-Rad Laboratories's life science — goodwill, period increase (decrease).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bio-Rad Laboratories's life science — goodwill, period increase (decrease)?: Bio-Rad Laboratories (BIO) reported life science — goodwill, period increase (decrease) of -$2.7M in Q1 2026.
What is the long-term trend for Bio-Rad Laboratories's life science — goodwill, period increase (decrease)?: Over 3 years (2021 to 2025), Bio-Rad Laboratories's life science — goodwill, period increase (decrease) has grown at a 43.0% compound annual growth rate (CAGR), from $55.4M to $162.1M.
What does life science — goodwill, period increase (decrease) mean?: The net change in the goodwill balance for the Life Science segment during the reporting period. This includes new acquisitions, divestitures, and adjustments for impairment or currency translation.